A detailed history of True Capital Management transactions in Novo Nordisk A S stock. As of the latest transaction made, True Capital Management holds 1,502 shares of NVO stock, worth $157,049. This represents 0.16% of its overall portfolio holdings.

Number of Shares
1,502
Holding current value
$157,049
% of portfolio
0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

BUY
$132.34 - $159.14 $198,774 - $239,028
1,502 New
1,502 $239 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track True Capital Management Portfolio

Follow True Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on True Capital Management with notifications on news.